6.
Wang P, Gao W, Wang Y, Wang J
. Acetylshikonin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant oral cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway. J BUON. 2019; 24(5):2062-2067.
View
7.
Brown J, Wouters B
. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 1999; 59(7):1391-9.
View
8.
Hammond W, Swaika A, Mody K
. Pharmacologic resistance in colorectal cancer: a review. Ther Adv Med Oncol. 2016; 8(1):57-84.
PMC: 4699262.
DOI: 10.1177/1758834015614530.
View
9.
Liu B, Chen Y, St Clair D
. ROS and p53: a versatile partnership. Free Radic Biol Med. 2008; 44(8):1529-35.
PMC: 2359898.
DOI: 10.1016/j.freeradbiomed.2008.01.011.
View
10.
Davies H, Bignell G, Cox C, Stephens P, Edkins S, Clegg S
. Mutations of the BRAF gene in human cancer. Nature. 2002; 417(6892):949-54.
DOI: 10.1038/nature00766.
View
11.
Lin K, Chien C, Tseng C, Chen Y, Chang L, Lin S
. Furano-1,2-Naphthoquinone Inhibits Src and PI3K/Akt Signaling Pathways in Ca9-22 Human Oral Squamous Carcinoma Cells. Integr Cancer Ther. 2012; 13(3):NP18-28.
DOI: 10.1177/1534735411433834.
View
12.
Trott O, Olson A
. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009; 31(2):455-61.
PMC: 3041641.
DOI: 10.1002/jcc.21334.
View
13.
Gulati A, Yang Y, Harter D, Mukhopadhyay A, Aggarwal B, Aggarwal B
. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1. Mol Carcinog. 2005; 45(1):26-37.
DOI: 10.1002/mc.20149.
View
14.
Randhawa H, Kibble K, Zeng H, Moyer M, Reindl K
. Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicol In Vitro. 2013; 27(6):1626-33.
PMC: 3749270.
DOI: 10.1016/j.tiv.2013.04.006.
View
15.
De Luca A, Maiello M, DAlessio A, Pergameno M, Normanno N
. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets. 2012; 16 Suppl 2:S17-27.
DOI: 10.1517/14728222.2011.639361.
View
16.
Hairani R, Mongkol R, Chavasiri W
. Allyl and prenyl ethers of mansonone G, new potential semisynthetic antibacterial agents. Bioorg Med Chem Lett. 2016; 26(21):5300-5303.
DOI: 10.1016/j.bmcl.2016.09.044.
View
17.
Macip S, Igarashi M, Berggren P, Yu J, Lee S, Aaronson S
. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol. 2003; 23(23):8576-85.
PMC: 262651.
DOI: 10.1128/MCB.23.23.8576-8585.2003.
View
18.
Wang J, Shen G, Luo Y, Piao X, Shen M, Liu C
. The compound 2-(naphthalene-2-thio)-5,8-dimethoxy-1,4-naphthoquinone induces apoptosis via reactive oxygen species-regulated mitogen-activated protein kinase, protein kinase B, and signal transducer and activator of transcription 3 signaling in.... Drug Dev Res. 2018; 79(6):295-306.
DOI: 10.1002/ddr.21442.
View
19.
Rattanawong A, Payon V, Limpanasittikul W, Boonkrai C, Mutirangura A, Wonganan P
. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1. Oncol Rep. 2017; 39(1):227-238.
DOI: 10.3892/or.2017.6084.
View
20.
Lu Z, Xu S
. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life. 2006; 58(11):621-31.
DOI: 10.1080/15216540600957438.
View